ClinicalTrials.gg
Sign In

EssilorLuxottica clinical trials

The registry lists 63 studies whose lead sponsor is EssilorLuxottica or one of 3 companies grouped under it. 23 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 13, 2026.

Our grouping of 4 registry names, not the registry’s. See them and correct one ↓

Get an email when these change. Save the EssilorLuxottica studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Coming up

9 of EssilorLuxottica’s studies under way reach primary completion within a year, 1 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 1N’26
  2. 1D
  3. J’27
  4. F
  5. M
  6. A
  7. 2M
  8. 1J
  9. J
  10. 1A
  11. S
  12. 1O
  13. 2N

All 9

Show 4 more

Add all 9 to your calendar (.ics) → With an account.

All 63 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now2337%Recruiting 14 · Not yet recruiting 9
  • Under way, not recruiting610%
  • Completed2844%
  • Stopped early58%
  • Status unknown or other12%

Phase

  • Phase 21
  • Phase 31

Where

  • United States20
  • France14
  • Singapore11
  • Canada3
  • Italy1
  • China1

Over the years

  1. 12
  2. 13
  3. 14
  4. 15
  5. 16
  6. 17
  7. 18
  8. 19
  9. 20
  10. 21
  11. 22
  12. 23
  13. 24
  14. 25
  15. 1426

By the year each study started; 1 started before 2012. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to EssilorLuxottica.

  • Essilor International
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    38 studies
  • Heidelberg Engineering GmbH
    Acquired — became part of EssilorLuxottica, Oct 2, 2024 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    22 studies →
  • Nuance Hearing
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Essilor-Polylite Taiwan Co., Ltd.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions EssilorLuxottica leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Myopia26Refractive Errors17

Studies

Recruiting first, then most recently updated. Showing 50 of 63. Browse all 63 →